Otsuka America Pharmaceutical and Avanir Pharmaceuticals are working with southern New Jersey educational administrators to create specialists who can help…
Articles by Ana de Barros, PhD
The Jackson Laboratory (JAX) is receiving a $2.7 million U.S. government grant for a five-year research project on the mechanisms that…
Actors on CBS’s hit television series “Criminal Minds” have made a commercial to promote an Alzheimer’s Association awareness event called…
The Dementia Discovery Fund will pump $5 million in initial financing into Cerevance, a start-up developing new approaches to treating…
Neurotrope‘s investigational drug bryostatin might improve cognition and the ability of patients with moderate to severe Alzheimer’s disease to…
Canada’s ProMIS Neurosciences today presented the latest results of its Alzheimer’s disease therapeutic program and discussed its lead candidate drug PMN 310…
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) seeks help from leading experts, pharmaceutical companies and nonprofit organizations around the world to…
The high concentration of vitamin B12 in Marmite — a distinctly British food spread that many say is an acquired…
British pharmaceutical company Neuro-Bio has received $3.2 million in financing from Los Angeles-based Kairos Ventures to continue developing a diagnostic tool…
The University of Wisconsin-Madison’s Alzheimer’s Disease Research Center and Cerveau Technologies are partnering in research on the stages of Alzheimer’s and…